The Bayer Group's "2010 Media Forum on Innovative Futures" was recently held in Germany. More than 140 journalists from major media around the world attended the forum. Bayer Management Board** Dr. Dykes said at the conference: “Bayer has a very successful history of innovation. Its R&D expenditure reached a record of 3.1 billion euros in 2010, a growth rate of 13%. Over the years, Bayer’s R&D budget It is always second to none in the German chemical and pharmaceutical industry."
What changes can the innovation bring to the company? Dr. Dykes believes that the company's innovative activities can benefit patients, farmers and other customers around the world. He said: "As a company, we also need to innovate. This is the key to ensuring the smooth operation of the company. In order to succeed in fierce competition, we need to rely on innovative development and related marketing."
According to reports, innovation has become an integral part of Bayer. At present, about 12,500 employees of Bayer's R&D department play a central role in this area. Dax stressed that the company's solutions can meet the major challenges that it faces in the future. He said that the global population is expected to increase from the current nearly 7 billion to more than 9 billion by 2050. In addition, human life expectancy is also increasing year by year. Specifically, this means that the demand for health services will increase from diagnosis and even disease treatment. Dax said: "Bayer's medical and health business sub-group complies with this trend." He added that although the area of ​​cultivated land is limited, it must still ensure that the global population growth trend to provide adequate health food. In this regard, as a scientific business subgroup, we are committed to providing solutions aimed at increasing productivity. In addition, more effective methods of energy and resource use must be adopted while significantly improving the living standards of emerging economies. Daeks explained: "With the high-tech article sourced by Global Polyurethane Net Technology Materials, our materials technology business can make a great contribution in this regard."
It is reported that Bayer MaterialScience and its customers and external partners work together to develop new products and new applications as well as ultra-modern technology and production processes, while making full use of alternative raw materials to minimize energy consumption. For example, waste products and carbon dioxide can be used as raw materials for future high-tech materials, thus replacing some of the traditional fossil-based raw materials. In the DreamProduction project, Bayer collaborated with Aachen University and other partners to realize the catalytic conversion of carbon dioxide for the first time on a pilot plant scale.
Bayer is also actively developing innovative materials for the production of energy through renewable resources. At present, their products include polyurethane modules with integrated protection system for solar modules and polycarbonate splints with solar cells. In addition, Bayer materials can also significantly reduce energy consumption, which in turn reduces carbon dioxide emissions from greenhouse gases in insulation applications such as automotive engineering or building and refrigeration equipment.
In the consumer electronics industry, Bayer also maintains a leading position in the field of electroactive polymers. Its high-tech materials are widely used in the development, design, and manufacture of actuators and sensing elements, and they bring a wide range of opportunities: touch screens made of such high-tech materials can be truly realized by creating true tactile feedback. Touch awareness."